"Aptose is incredibly grateful for Hanmi's continued support tuspetinib,” said William G. Rice, Ph.D., Chairman, President ...

The licensing agreement grants Aché exclusive rights to sell Triple Hair's Therapy-07 prescription drug in Brazil. The agreement comprises upfront payments, milestone payments, and royalties on ...

Ocugen has a valuable IP portfolio, which should give it funding options. OCGN’s cash runway remains the main risk. Check out ...

General’s report lists a litany of expensive mistakes leading to the failed attempt to install a lifesaving proton therapy ...

Investing.com -- Carisma Therapeutics Inc (NASDAQ: CARM) stock jumped 9.1% following the announcement of a definitive merger agreement with OrthoCellix, a wholly-owned subsidiary of Ocugen Inc (NASDAQ ...

Shares of Verve Therapeutics (NASDAQ: VERV) were skyrocketing 75.7% higher as of 10:50 a.m. ET on Tuesday. Eli Lilly (NYSE: ...

Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...

A Maricopa County juvenile court commissioner handed out the judgment in the case of a Gilbert barn arson. Here's what ...

Qure's stock aligns with intrinsic value due to HEMGENIX challenges. Regulatory milestones de-risk pipeline; cash runway ...

Teva Pharmaceutical TEVA announced that it has entered into a strategic collaboration agreement with China-based Fosun ...

Strategic actions by Supernus, Teva, Incyte, and BioNTech highlight growing momentum in advancing clinical-stage therapies ...

A new consensus statement endorsed by the National Psoriasis Foundation formally defined on-treatment remission for plaque ...